UiPath (PATH) has crashed so hard since the most recent earnings report that it is one of the few tech stocks that is still trading at around the 2022 lows. What happened? It appears that the market ...
UiPath Inc. (PATH) may have been forgotten as a “has-been” software player amidst the rise of generative AI. The company has, however, rolled out new products that integrate generative AI into its RPA ...
UiPath (NYSE: PATH) isn't just an automation company anymore. It's quietly transforming into a key infrastructure player at the intersection of automation, data, and artificial intelligence (AI). To ...
Hosted on MSN
Mastering UiPath and OpenAI for smarter automations
UiPath’s integration with OpenAI is elevating automation by combining RPA’s precision with generative AI’s ability to interpret and create content. This blend enables bots to process unstructured data ...
UiPath Inc. (NYSE:PATH) is one of the best mid cap AI stocks to buy right now. UiPath Inc. (NYSE:PATH) is one of the best midcap AI stocks to buy right now. On August 1, 2025, UiPath announced the ...
Its old business model is being challenged by current AI innovations. UiPath's Agent Builder software is gathering a lot of attention. The stock is valued at a dirt-cheap level, indicating investor ...
The conversation at UiPath on Tour London 2025 made one thing clear – generative AI, while pervasive, has yet to deliver material value at scale. In fact, it is “everywhere except in the P&L," as ...
So I wrote an epic missive on the absurdity of AI agent overhype, hopped on a plane to Vegas, to hear UiPath make splashy news announcements about... AI agents. How did that go over with me? A bit ...
Artificial intelligence is a phrase that can inspire awe or fear, depending on who you’re talking to. This fear is valid, says Manasi Vartak, the chief AI architect at Cloudera, but it may ultimately ...
NEW YORK & BOCA RATON, Fla.--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it is transforming operations for Omega Healthcare, a ...
BigBear.ai is struggling to grow its core business. UiPath’s high-growth days are over, but the RPA market is still expanding. One of these niche AI stocks is clearly a better buy. BigBear.ai develops ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results